100 related articles for article (PubMed ID: 26694749)
1. Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents.
Sonn KA; Kannan AS; Bellary SS; Yun C; Hashmi SZ; Nelson JT; Ghodasra JH; Nickoli MS; Parimi V; Ghosh A; Shawen N; Ashtekar A; Stock SR; Hsu EL; Hsu WK
J Orthop Res; 2016 Jul; 34(7):1274-81. PubMed ID: 26694749
[TBL] [Abstract][Full Text] [Related]
2. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer.
Molina CA; Sarabia-Estrada R; Gokaslan ZL; Witham TF; Bydon A; Wolinsky JP; Sciubba DM
J Neurosurg Spine; 2012 Apr; 16(4):365-72. PubMed ID: 22264176
[TBL] [Abstract][Full Text] [Related]
3. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases.
Balseiro S; Nottmeier EW
Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2-mediated pain and inflammation in a rat model of posterolateral arthrodesis.
Mitchell K; Shah JP; Dalgard CL; Tsytsikova LV; Tipton AC; Dmitriev AE; Symes AJ
BMC Neurosci; 2016 Dec; 17(1):80. PubMed ID: 27905881
[TBL] [Abstract][Full Text] [Related]
5. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
[TBL] [Abstract][Full Text] [Related]
6. Multimodality imaging for vertebral metastases in a rat osteolytic model.
Burch S; Bisland SK; Wilson BC; Whyne C; Yee AJ
Clin Orthop Relat Res; 2007 Jan; 454():230-6. PubMed ID: 16924176
[TBL] [Abstract][Full Text] [Related]
7. Metastatic human breast cancer to the spine produces mechanical hyperalgesia and gait deficits in rodents.
Sarabia-Estrada R; Ruiz-Valls A; Guerrero-Cazares H; Ampuero AM; Jimenez-Estrada I; De Silva S; Bernhardt LJ; Goodwin CR; Ahmed AK; Li Y; Phillips NA; Gokaslan ZL; Quiñones-Hinojosa A; Sciubba DM
Spine J; 2017 Sep; 17(9):1325-1334. PubMed ID: 28412561
[TBL] [Abstract][Full Text] [Related]
8. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
Fritz V; Louis-Plence P; Apparailly F; Noël D; Voide R; Pillon A; Nicolas JC; Müller R; Jorgensen C
Bone; 2007 Apr; 40(4):1032-40. PubMed ID: 17251073
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
10. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion.
Helgeson MD; Lehman RA; Patzkowski JC; Dmitriev AE; Rosner MK; Mack AW
Spine J; 2011 Jun; 11(6):507-10. PubMed ID: 21729801
[TBL] [Abstract][Full Text] [Related]
11. A rat model of metastatic spinal cord compression using human prostate adenocarcinoma: histopathological and functional analysis.
Sarabia-Estrada R; Zadnik PL; Molina CA; Jimenez-Estrada I; Groves ML; Gokaslan ZL; Bydon A; Witham TF; Wolinsky JP; Sciubba DM
Spine J; 2013 Nov; 13(11):1597-606. PubMed ID: 23810458
[TBL] [Abstract][Full Text] [Related]
12. Osteolytic and mixed cancer metastasis modulates collagen and mineral parameters within rat vertebral bone matrix.
Burke MV; Atkins A; Akens M; Willett TL; Whyne CM
J Orthop Res; 2016 Dec; 34(12):2126-2136. PubMed ID: 27027407
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine.
Taneichi H; Kaneda K; Takeda N; Abumi K; Satoh S
Spine (Phila Pa 1976); 1997 Feb; 22(3):239-45. PubMed ID: 9051884
[TBL] [Abstract][Full Text] [Related]
14. The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
Mendoza MC; Sonn KA; Kannan AS; Bellary SS; Mitchell SM; Singh G; Park C; Yun C; Stock SR; Hsu EL; Hsu WK
J Neurosurg Spine; 2016 Aug; 25(2):147-53. PubMed ID: 27035510
[TBL] [Abstract][Full Text] [Related]
15. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
[TBL] [Abstract][Full Text] [Related]
16. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
[TBL] [Abstract][Full Text] [Related]
17. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
18. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases.
Lewandrowski KU; Nanson C; Calderon R
Spine J; 2007; 7(5):609-14. PubMed ID: 17526434
[TBL] [Abstract][Full Text] [Related]
19. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of bone morphogenetic proteins 2 and 7 by ex vivo gene therapy in a rat spinal fusion model.
Kaito T; Johnson J; Ellerman J; Tian H; Aydogan M; Chatsrinopkun M; Ngo S; Choi C; Wang JC
J Bone Joint Surg Am; 2013 Sep; 95(17):1612-9. PubMed ID: 24005203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
